SystImmune Achieves FDA Clearance for Innovative Bispecific Antibody SI-B037 #USA #FDA_Clearance #SystImmune #Redmond #SI-B037

SystImmune to Unveil Novel Data on Iza-bren at WCLC Congress 2026, Targeting Lung Cancer Treatment #United_States #SystImmune #Redmond #Iza-bren #EGFR-mutated